Daniel Lang

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Buffalo, NY
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/Steven Adams, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Daniel Lang

Form 4 holding Pres Cell Therapy, VP Corp Dev

Athenex, Inc.

Security class
Common Stock
Shares / value
81,590
Estimated value
$110,962
Report date
16 Sep 2022
Price
$1.36
Ownership
Direct
Form 4 holding Pres Cell Therapy, VP Corp Dev

Athenex, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
200,000
Estimated value
Report date
16 Sep 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
200,000
Form 4 holding Pres Cell Therapy, VP Corp Dev

Athenex, Inc.

Security class
Restricted Stock Units
Shares / value
37,500
Estimated value
Report date
16 Sep 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Daniel Lang

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .